Abstract:T-Antigen (Gal-beta1,3-GalNAc-alpha-O-Ser/Thr) is an important precursor of mucin-type O-glycans. T-Antigen is found to be closely associated with cancer progression and metastasis and has been used to develop carbohydrate-based anticancer vaccines. Enzymatic synthesis of T-antigen disaccharides have relied on the use of beta-1,3-galactosyltransferases recently cloned and characterized from several eukaryotic organisms. However, its application is limited by the difficulty of obtaining homogeneous enzymes and the strict substrate specificity of enzymes. Recently, a number of bacteria have been found to express carbohydrate structures that mimic host glycans. The corresponding glycosyltransferases have been exploited in the facile synthesis of a number of clinically important glycoconjugate mimics. In this study, we biochemically characterized a bacterial beta-1,3-galactosyltransferase (WbiP) from Escherichia coli O127, which expresses a T-antigen mimic in the lipopolysaccharide (LPS) structure. Substrate study showed that WbiP could readily glycosylate a series of N-acetylgalactosamine (GalNAc) analogues with alpha-substitutions at the reducing end, including glycosylated Ser and Thr (GalNAc-alpha-O-Ser/Thr), which illustrates the use of WbiP for the facile synthesis of T-antigens. Alignment of a group of putative bacterial beta-1,3-galactosyltransferases revealed the presence of two conserved DXD motifs, possibly suggesting a different functional role of each motif. Site-directed mutagenesis, enzyme kinetics as well as UDP-bead binding assays were carried out to investigate the role of each DXD motif in WbiP. The results suggest that 88DSD90 is critical in the binding of sugar donor UDP-Gal, whereas 174DYD176 may participate in the binding of the sugar acceptor. This study expands the scope of using bacterial glycosyltransferases as tools for in vitro synthesis of glycoconjugate mimics with clinical significance.

Glycosyltransferase Genes: Applications to Medical Science

Glycosylation in the Tumor Immune Response: the Bitter Side of Sweetness

Characterization of a Bacterial Beta-1,3-galactosyltransferase with Application in the Synthesis of Tumor-Associated T-antigen Mimics.

A Tandem Enzymatic Approach for Detecting and Imaging Tumor-Associated Thomsen-Friedenreich Antigen Disaccharide.

Tumor-associated antigens: Tn antigen, sTn antigen, and T antigen

Altered glycosylation in cancer: molecular functions and therapeutic potential

The roles of OGT and its mechanisms in cancer

The extended ppGalNAc-T family and their functional involvement in the metastatic cascade

Impacts of β-1, 3-N-acetylglucosaminyltransferases (B3GNTs) in human diseases

O-glycan recognition and function in mice and human cancers

Glycosylation: mechanisms, biological functions and clinical implications

Role of glycosylation in TGF-β signaling and epithelial-to-mesenchymal transition in cancer

The Role of Glycosyltransferases in Colorectal Cancer

Characterization of galactosyltransferase and sialyltransferase genes mediating the elongation of the extracellular O-GlcNAc glycans

Glycan changes: cancer metastasis and anti-cancer vaccines

Human T cell glycosylation and implications on immune therapy for cancer

The role of N-glycosylation modification in the pathogenesis of liver cancer

Roles of glycosylation at the cancer cell surface: opportunities for large scale glycoproteomics

Glycosylation in cancer as a source of biomarkers

Glycobiology of the Epithelial to Mesenchymal Transition

Novel regulatory mechanisms of N-glycan sialylation: Implication of integrin and focal adhesion kinase in the regulation